StockWatch
·
Pharmaceuticals
Acquisitions17 Nov 2026, 10:11 am

Sai Parenterals Subsidiary to Acquire Majority Stake in Bion Therapeutics

AI Summary

Sai Parenterals Limited, through its wholly owned subsidiary SP Analytics Private Limited, has entered into a definitive agreement to acquire a majority stake in Bion Therapeutics India Private Limited (Bion). Bion, a Hyderabad-based branded formulations prescription business, will become a step-down subsidiary upon deal completion, expected by month-end. This all-cash transaction adds 16 established brands and approximately 250 field staff, significantly strengthening Sai Parenterals' presence in India's prescription market. Bion operates across 12 states with a strong presence in South, East, and Northeast India, focusing on niche therapeutic segments. The acquisition integrates Bion's doctor-led brands and distribution network with Sai Parenterals' manufacturing capabilities and R&D. The transaction will be funded through internal accruals, debt, and IPO proceeds.

Key Highlights

  • Sai Parenterals to acquire majority stake in Bion Therapeutics via subsidiary SP Analytics.
  • Acquisition adds 16 established brands and 250 field staff to strengthen prescription market presence.
  • Transaction is an all-cash deal funded by internal accruals, debt, and IPO proceeds.
  • Bion will become a step-down subsidiary post-completion, expected by month-end.